Co-delivery of T helper 1-biasing cytokine genes enhances the efficacy of gene gun immunization of mice: studies with the model tumor antigen β-galactosidase and the BALB/c Meth A p53 tumor-specific antigen
Open Access
- 1 April 1999
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 6 (4) , 629-636
- https://doi.org/10.1038/sj.gt.3300859
Abstract
DNA-based immunization is currently being investigated as a new method for the induction of cellular and humoral immunity directed against viral disease and cancer. In the present study we characterized and compared the immune responses induced in mice following particle-bombardment of the skin (‘gene gun’ immunization) with those elicited by intracutaneous injection of a recombinant adenoviral vector. Using the well characterized β-galactosidase (βgal) model Ag system we find that both in vivo gene transfer systems elicit potent and long-lasting anti-βgal-specific CD8+ and CD4+ T cell responses. However, gene gun immunization predominantly promotes the production of anti-βgal antibodies of the γ1 isotype, indicative of a Th2-biased immune response, while intradermal injection of recombinant adenovirus primarily leads to the production of anti-βgal γ2aantibodies, indicative of a Th1-biased immune response. Since viral infections are generally associated with the production of large amounts of IFN-α and IL-12, we investigated whether administration of expression plasmids encoding these Th1-associated cytokines along with antigen-encoding cDNA can influence the nature of the immune response resulting from gene gun immunization. We observed that co-delivery of IFN-α or IL-12 resulted in increased production of anti-βgal γ2aantibodies. This suggests a shift towards a Th1 phenotype of the resulting immune response, thus mimicking a viral infection. Importantly, gene gun immunization of mice with a naturally occurring tumor antigen, the tumor-specific p53 mutant antigen expressed by the chemically induced BALB/c Meth A sarcoma, required co-delivery of IL-12 for the induction of effective antitumor immunity. These results have important implications for the design of clinically relevant gene gun immunization strategies for tumor immunotherapy.Keywords
This publication has 17 references indexed in Scilit:
- Interferon-α gene therapy for cancer: retroviral transduction of fibroblasts and particle-mediated transfection of tumor cells are both effective strategies for gene delivery in murine tumor modelsGene Therapy, 1997
- DNA–based immunization by in vivo transfection of dendritic cellsNature Medicine, 1996
- Genetic vaccination: The advantages of going nakedNature Medicine, 1996
- Immunostimulatory DNA Sequences Necessary for Effective Intradermal Gene ImmunizationScience, 1996
- Immunoglobulin class switchingCurrent Opinion in Immunology, 1996
- Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines.The Journal of Experimental Medicine, 1996
- Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.The Journal of Experimental Medicine, 1996
- Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses.Proceedings of the National Academy of Sciences, 1994
- Regulation by interferon alpha of immunoglobulin isotype selection and lymphokine production in mice.The Journal of Experimental Medicine, 1991
- Cell surface antigens of chemically induced sarcomas of the mouse. I. Murine leukemia virus-related antigens and alloantigens on cultured fibroblasts and sarcoma cells: description of a unique antigen on BALB/c Meth A sarcoma.The Journal of Experimental Medicine, 1977